Burning Rock Biotech Ltd
NASDAQ:BNR
Burning Rock Biotech Ltd
Accounts Receivables
Burning Rock Biotech Ltd
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
Accounts Receivables
¥149.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Accounts Receivables
¥2.5B
|
CAGR 3-Years
86%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Accounts Receivables
¥1B
|
CAGR 3-Years
28%
|
CAGR 5-Years
166%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Accounts Receivables
¥3B
|
CAGR 3-Years
63%
|
CAGR 5-Years
74%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Accounts Receivables
¥27.1B
|
CAGR 3-Years
50%
|
CAGR 5-Years
53%
|
CAGR 10-Years
54%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Accounts Receivables
¥127.8m
|
CAGR 3-Years
106%
|
CAGR 5-Years
96%
|
CAGR 10-Years
N/A
|
See Also
What is Burning Rock Biotech Ltd's Accounts Receivables?
Accounts Receivables
149.6m
CNY
Based on the financial report for Dec 31, 2023, Burning Rock Biotech Ltd's Accounts Receivables amounts to 149.6m CNY.
What is Burning Rock Biotech Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
33%
Over the last year, the Accounts Receivables growth was -1%. The average annual Accounts Receivables growth rates for Burning Rock Biotech Ltd have been 11% over the past three years , 33% over the past five years .